PCC

BioAro Inc. to Donate Genomic Testing Free of Charge to 100 Prostate Cancer Centre Patients

Retrieved on: 
Tuesday, May 23, 2023

Together they will change the way metastatic prostate cancer patients are treated – improving the patients' quality of life as they navigate their treatment options.

Key Points: 
  • Together they will change the way metastatic prostate cancer patients are treated – improving the patients' quality of life as they navigate their treatment options.
  • BioAro will be providing complimentary genomic testing services for up to 100 eligible patients referred through specific Urologists of the Southern Alberta Institute of Urology (SAIU).
  • This is the first-time genomic testing, analysis and support for companion diagnostics of this magnitude has been offered at no cost to AB cancer patients from a local company.
  • BioAro Inc. is proud to undertake this initiative with the PCC to give the gift of equitable GenOMIC testing and information to prostate cancer families in need.

Advancements Series to Explore Improvements in Telehealth Connectivity

Retrieved on: 
Monday, May 22, 2023

JUPITER, Fla., May 22, 2023 /PRNewswire-PRWeb/ -- An upcoming segment of Advancements with Ted Danson will focus on recent innovations in telehealth technology.

Key Points: 
  • JUPITER, Fla., May 22, 2023 /PRNewswire-PRWeb/ -- An upcoming segment of Advancements with Ted Danson will focus on recent innovations in telehealth technology.
  • With a look at certain disparities being felt throughout the healthcare industry, Advancements will explore the need for broadband and telehealth services today.
  • "Each program participant received in person digital literacy training with a telehealth and health literacy segment, a laptop or tablet, and assistance with affordable internet solutions."
  • "PCC offers an array of technology and equipment solutions for implementing telehealth programs," said Richard Lubin, senior producer for the Advancements series.

FreightCar America, Inc. Announces Appointment of Nicholas J. Randall as Chief Operating Officer

Retrieved on: 
Thursday, May 18, 2023

CHICAGO, May 18, 2023 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (Nasdaq: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer of railroad freight cars, announced today the appointment of Nicholas J. Randall as the Company’s Chief Operating Officer (COO), effective June 26, 2023.

Key Points: 
  • CHICAGO, May 18, 2023 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (Nasdaq: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer of railroad freight cars, announced today the appointment of Nicholas J. Randall as the Company’s Chief Operating Officer (COO), effective June 26, 2023.
  • Randall will report to James R. Meyer, President and Chief Executive Officer.
  • “I am thrilled to welcome Nick to the FreightCar America team as our Chief Operating Officer.
  • He is an accomplished business leader with deep and global experience in the heavy durable industrial and consumer industries.

Innovaccer Chief Medical Officer David Nace, MD Joins HFMA's Healthcare Leadership Council

Retrieved on: 
Monday, May 15, 2023

SAN FRANCISCO, May 15, 2023 /PRNewswire/ -- Today Innovaccer Inc. announced that Chief Medical Officer David Nace, MD has joined the Healthcare Financial Management Association's (HFMA) Healthcare Leadership Council (HLC). As a member of the ten-person council, Dr. Nace will provide strategic advice to HFMA's national leadership regarding key issues that impact HFMA members and the healthcare finance profession. The influential membership association recently surpassed 100,000 members after 12 consecutive quarters of growth.

Key Points: 
  • SAN FRANCISCO, May 15, 2023 /PRNewswire/ -- Today Innovaccer Inc. announced that Chief Medical Officer David Nace, MD has joined the Healthcare Financial Management Association's (HFMA) Healthcare Leadership Council (HLC).
  • As a member of the ten-person council, Dr. Nace will provide strategic advice to HFMA's national leadership regarding key issues that impact HFMA members and the healthcare finance profession.
  • In his role as Chief Medical Officer for Innovaccer, Dr. Nace draws on over 30 years of experience as a physician executive in large healthcare systems, payer health plans, leading healthcare providers, and health information technology organizations.
  • Before joining Innovaccer and after a career in private practice, Dr. Nace held executive leadership roles in several leading healthcare organizations.

Global Next Generation Cancer Diagnostics Market to 2027: Featuring Abbott Laboratories, Abbvie, Advanced Cell Diagnostics, Agilent Technologies and Artivion Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 10, 2023

Moreover, supportive government initiatives and rising awareness are additional factors anticipated to boost growth during the forecast period.

Key Points: 
  • Moreover, supportive government initiatives and rising awareness are additional factors anticipated to boost growth during the forecast period.
  • Cancer is one of the leading causes of death worldwide, and the prevalence of the disease has been escalating at an alarming rate.
  • The PCC drives diverse initiatives to grow patient access to precision diagnostics using wide-ranging genomic testing, including next generation sequencing (NGS).
  • Advanced diagnostics for cancer represent a significant market opportunity for life sciences companies.

Dalriada brings in former Evotec executive Adam Davenport to lead strategy execution as Chief R&D Officer

Retrieved on: 
Wednesday, May 3, 2023

TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today that it has strengthened its executive leadership team, appointing Adam Davenport, Ph.D. as its Chief Research & Development Officer (CRDO).

Key Points: 
  • TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today that it has strengthened its executive leadership team, appointing Adam Davenport, Ph.D. as its Chief Research & Development Officer (CRDO).
  • Dr. Davenport joins from Evotec and will assume strategic and scientific execution responsibility for all of Dalriada’s programs, as well as its current and future R&D capabilities.
  • “I am thrilled to welcome Dr. Davenport to Dalriada as its new CRDO,” said Dr. Diana Kraskouskaya, Dalriada’s CEO and co-founder.
  • “Throughout his outstanding career at Evotec, Dr. Davenport has been at the forefront of drug discovery.

Minerals Technologies Reports First Quarter 2023 Earnings of $1.14 Per Share

Retrieved on: 
Thursday, April 27, 2023

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today reported earnings per share of $1.14 for the first quarter ended April 2, 2023.

Key Points: 
  • Record First Quarter Sales of $546 Million, 5 Percent Above Prior Year
    Operating Income of $63 Million, Increased 43 Percent Sequentially
    NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) today reported earnings per share of $1.14 for the first quarter ended April 2, 2023.
  • Effective January 1, 2023, the Company realigned its business reporting structure and reorganized into two segments, Consumer & Specialties and Engineered Solutions.
  • “Minerals Technologies has transformed over the past 5 years into a more balanced portfolio of businesses poised for long-term sustainable growth.
  • Minerals Technologies will host a conference call tomorrow, April 28, 2023, at 11 a.m. Eastern Time.

Marketing Company Sustained 6-year Growth: How Did They Do It?

Retrieved on: 
Wednesday, April 26, 2023

The company accomplished this by focusing on just one industry vertical, and knowing it inside and out.

Key Points: 
  • The company accomplished this by focusing on just one industry vertical, and knowing it inside and out.
  • By committing to one vertical, the group has the bandwidth to fully immerse itself in the industry.
  • "We are the number one online marketing agency serving Podiatrists only," said Jeff Hartman, CEO of Podiatry Content Connection (PCC).
  • Podiatry Content Connection clients make more money than those Podiatrists who use other marketing agencies, according to Chase Bank Customer Insights.

BGSF, Inc. Expands Its Board of Directors

Retrieved on: 
Thursday, April 20, 2023

Carroll founded Human Factor Consulting, LLC during the pandemic to provide board advisory, consulting, and leadership development to the public sector and non-profit organizations.

Key Points: 
  • Carroll founded Human Factor Consulting, LLC during the pandemic to provide board advisory, consulting, and leadership development to the public sector and non-profit organizations.
  • The Board will consider which of the Boards committee(s) she may serve on during the next Board meeting.
  • Beth Garvey, Chair, President, and Chief Executive Officer, commented, “We are excited to welcome Donna to the BGSF’s Board of Directors.
  • I am thrilled to step alongside Beth Garvey and her leadership team to serve on the Board of Directors of BGSF and be a part of supporting their continued success.”

Minerals Technologies Further Expands in China and India Paper Markets

Retrieved on: 
Tuesday, April 18, 2023

The agreements are with three major paper companies – Andhra Paper Limited located in Rajahmundry, India; Nine Dragons Paper located in Beihai, China; and Zhejiang Zhefeng New Materials Company located in Quzhou, China – to build and operate on-site precipitated calcium carbonate (PCC) satellite plants.

Key Points: 
  • The agreements are with three major paper companies – Andhra Paper Limited located in Rajahmundry, India; Nine Dragons Paper located in Beihai, China; and Zhejiang Zhefeng New Materials Company located in Quzhou, China – to build and operate on-site precipitated calcium carbonate (PCC) satellite plants.
  • “MTI continues to drive growth in China and India as our newest technologies enable us to penetrate further into the paper market,” said Douglas T. Dietrich, Chairman and Chief Executive Officer.
  • “These new partnerships demonstrate that MTI is the technology leader in paper and packaging filler technologies.”
    D.J.
  • Monagle III, Group President, Consumer & Specialties, commented further, “We are pleased to provide our unique technologies that deliver significant efficacy and sustainability benefits.